Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

Share Price is delayed by 15 minutes
Get Live Data
173.50    1.00 (0.58%)
Bid:
170.00
Ask:
177.00
Spread: 7.00 (4.118%)
Market Cap: £9.57m
TND Live PriceLast checked at - London Stock Exchange

Intraday Tandem Group Share Chart

Directorate Changes

31 Jan 2025 07:00

RNS Number : 0196V
Tandem Group PLC
31 January 2025
 

31 January 2025

 

Tandem Group plc

(the 'Company' and together with its subsidiaries the 'Group')

Directorate Changes

 

Tandem Group plc (AIM: TND), designers, developers, distributors and retailers of sports, leisure and e-mobility equipment, is pleased to announce that Dave Poulter, Chief Commercial Officer of the Tandem Group Trading Limited, the Group's main trading subsidiary, has been appointed as an executive director of the Company with immediate effect.

With over 25 years of retail sector experience, Dave previously held several senior roles at Halfords PLC and joined the Group in July 2024. Prior to acting as Buying/Value Chain Director and Motoring Category Director at Halfords PLC, Dave held various senior positions at Dixons Group PLC and Budget Rent A Car, further enhancing his skills in category management and commercial strategy.

Alongside his professional achievements, he holds a Diploma in Marketing, a Diploma in Management Studies.

The Company also announces that after 25 years with the Company, including 12 years as Group Commercial Director, Phil Ratcliffe will step down from the Board with immediate effect and retire from full-time employment with the Company on 21 May 2025. The Board would like to extend its thanks to Phil for his significant contributions to the Group during his tenure.

Stephen Grant, Non-Executive Chairman of the Company, commented:

"I am delighted to welcome Dave to the Board. With over 25 years of expertise in retail and buying and a proven track record of driving growth and innovation, Dave brings invaluable strategic insight and leadership. I look forward to the Company benefiting from his experience and the complementary skills he brings to the Board.

In addition, I would like to thank Phil for his dedication and exceptional service. His contributions have helped shape the success of the Group, and we are deeply grateful for his commitment over the last 25 years."

 

For further information:

 Enquiries:

Tandem Group plc

Peter Kimberley, Chief Executive Officer

Gurvinder Kaur, Chief Financial Officer

Telephone 0121 748 8075

 

Nominated Adviser

Cavendish Capital Markets Limited

Ben Jeynes / Dan Hodkinson - Corporate Finance

Michael Johnson / Charlie Combe - Sales and Equity Capital Markets

Telephone 020 7220 0500

 

Current

Previous

The Abbots Projects Limited

 

In addition to his appointment to the Tandem Board, David Richard Poulter, aged 55, holds or has held the following directorships or partnerships in the past five years.

 

At the date of appointment, Dave holds no shares in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEIFWAEISEEF
Date   Source Headline
20th Apr 20167:00 amRNSGrant and exercise of share options
19th Apr 20167:00 amRNSFinal Results
6th Apr 20161:26 pmRNSHolding(s) in Company
9th Mar 20167:00 amRNSTrading Statement
26th Oct 20151:18 pmRNSHolding(s) in Company
9th Oct 20157:00 amRNSExercise of Options
8th Oct 20157:00 amRNSAcquisition Update
29th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSAcquisition
24th Jun 20157:31 amRNSResult of AGM
23rd Jun 20157:00 amRNSExercise of options
23rd Jun 20157:00 amRNSAGM Statement
18th May 20152:54 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSFinal Results
17th Feb 20157:00 amRNSTrading Statement
19th Sep 20147:00 amRNSHalf Yearly Report
11th Sep 20147:00 amRNSHolding(s) in Company
9th Sep 20147:00 amRNSHolding(s) in Company
21st Aug 20148:51 amRNSHolding(s) in Company
4th Aug 20142:03 pmRNSAcquisition
24th Jun 201410:01 amRNSHolding(s) in Company
10th Jun 20145:11 pmRNSResult of AGM
10th Jun 20147:00 amRNSAGM Statement
4th Apr 201412:06 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSFinal Results
6th Feb 201411:24 amRNSTrading Statement
30th Oct 20132:13 pmRNSGrant of options and Director's shareholding
20th Sep 20137:00 amRNSHalf Yearly Report
28th Jun 20132:58 pmRNSDirector/PDMR Shareholding
7th Jun 20131:13 pmRNSDirector/PDMR Shareholding
4th Jun 20134:36 pmRNSResult of AGM
4th Jun 201311:00 amRNSAGM Statement
31st May 20131:34 pmRNSTotal Voting Rights
10th May 20131:34 pmRNSHolding(s) in Company
1st May 20132:38 pmRNSExercise of options and Directors' shareholdings
10th Apr 20132:22 pmRNSDirector/PDMR Shareholding
2nd Apr 201310:26 amRNSDirector/PDMR Shareholding
28th Mar 20137:00 amRNSFinal Results
6th Feb 20137:00 amRNSAcquisition and Trading Update
4th Dec 20123:45 pmRNSTotal Voting Rights
23rd Nov 201210:38 amRNSTransaction in Own Shares
9th Nov 20121:49 pmRNSTransaction in Own Shares
2nd Nov 20127:00 amRNSTotal Voting Rights
29th Oct 20127:00 amRNSTransaction in Own Shares
15th Oct 20123:49 pmRNSTransaction in Own Shares
9th Oct 201210:07 amRNSTransaction in Own Shares
1st Oct 20123:04 pmRNSTotal Voting Rights
28th Sep 20129:46 amRNSTransaction in Own Shares
21st Sep 20127:00 amRNSHalf Yearly Report
29th Jun 20125:01 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.